MBZUAI has announced partnerships with IBT and BioMap to advance AI applications in healthcare. The collaboration with IBT will focus on developing personalized digital therapeutics for brain health. The partnership with BioMap will establish a biocomputing innovation research lab in the Middle East focused on AI-generated proteins. Why it matters: These partnerships highlight MBZUAI's commitment to leveraging AI for personalized healthcare solutions and establishing the UAE as a hub for biocomputing innovation.
MBZUAI hosted AI Innovation Day, uniting over 200 UAE leaders from healthcare, government, science, and research to foster collaborations in AI-driven healthcare. The event featured sessions on multimodal foundation models, human genomics, longevity science, and robotics-enabled therapeutics. UAE's Minister of Health and Prevention, H.E. Ahmed bin Ali Al Sayegh, emphasized AI's fundamental role in the future of healthcare in the UAE. Why it matters: The event highlights the UAE's commitment to becoming a global hub for digital healthcare research and innovation, positioning MBZUAI as a key driver in the region's healthcare ecosystem.
MBZUAI and MIT Schwarzman College of Computing have launched a collaborative research program to advance AI across scientific discovery, human thriving, and planetary health. The program will involve faculty, students, and research staff from both institutions, with projects jointly led by principal investigators from each. The collaboration aims to strengthen AI foundations and accelerate its application to pressing societal challenges, aligning with both MIT's goals and the UAE's mission to become a global AI innovation hub. Why it matters: This partnership between a leading UAE AI university and a top US institution will foster impactful AI research and development, contributing to both regional and global advancements in the field.
MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.
MBZUAI and Cleveland Clinic Abu Dhabi jointly showcased AI applications to address UAE healthcare challenges, focusing on diabetes, heart disease, and vision loss. The event highlighted AI-powered robots for surgical tool guidance, autonomous ultrasound systems, and AI-based eye diagnostics for early disease detection. Researchers presented advances in AI-powered intrabody navigation, robotic ultrasound imaging, and AI-based oculomics. Why it matters: These AI innovations have the potential to transform healthcare delivery in the UAE, improving surgical outcomes, democratizing access to diagnostic imaging, and enabling earlier disease detection.